Sana Biotechnology (SANA) Profit After Tax (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Profit After Tax data on file, last reported at -$47.2 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 4.38% year-over-year to -$47.2 million; the trailing twelve-month figure through Mar 2026 stood at -$242.0 million (down 15.97% YoY), and the FY2025 full-year result was -$244.2 million, up 8.47% from the prior year.
• Profit After Tax advanced to -$47.2 million in Q1 2026, from -$58.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.6 million in Q3 2023 to a low of -$114.0 million in Q2 2023.
• A 5-year average of -$65.5 million and a median of -$59.9 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax surged 101.93% in 2023 and slumped 3738.37% in 2024, its largest moves.
• Tracing SANA's Profit After Tax over 5 years: stood at -$83.4 million in 2022, then decreased by 5.65% to -$88.1 million in 2023, then surged by 44.31% to -$49.1 million in 2024, then dropped by 19.88% to -$58.8 million in 2025, then gained by 19.69% to -$47.2 million in 2026.
• Business Quant data shows SANA's Profit After Tax at -$47.2 million in Q1 2026, -$58.8 million in Q4 2025, and -$42.2 million in Q3 2025.